NCT03991806

Brief Summary

This study evaluates the frailty and the health adverse events in the population of the Canadian Longitudinal Study on Aging. It will be used the Centre of Excellence Self-Administered questionnaire (CESAM) which assesses frailty of older adults by providing a score and a of frailty in 4 levels.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2020

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 14, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 19, 2019

Completed
12 months until next milestone

Study Start

First participant enrolled

May 31, 2020

Completed
4.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2025

Completed
Last Updated

February 23, 2024

Status Verified

February 1, 2024

Enrollment Period

4.6 years

First QC Date

June 14, 2019

Last Update Submit

February 22, 2024

Conditions

FrailtyCognitive DeclineInjuriesFall Injury

Outcome Measures

Primary Outcomes (1)

  • Dementia

    The algorithm is a three- step process involving administration of the neuropsychological battery to develop composite score in the three domains-memory, executive function, and psychomotor speed. The primary outcome of the study will be to determine the number of participants to whom the memory, the executive function, and the psychomotor speed are affected.

    around 18 months

Secondary Outcomes (1)

  • Medication

    around 18 months

Interventions

ObsservationalOTHER

The frailty and the health adverse events of older adults will be assessed by using a questionnaire called: Association of Centre of Excellence Self-Administered questionnaire (CESAM).

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

In this research study take part people that are enrolled in the Canadian Longitudinal Study on Aging. Moreover, they are community dwellers who are frequently exposed to different health adverse events.

You may qualify if:

  • Being 65 years and over
  • Being enrolled in the Canadian Longitudinal Study on Aging

You may not qualify if:

  • Never being enrolled in the Canadian Longitudinal Study on Aging
  • Undisclosed health adverse events

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Jewish General Hospital

Montreal, Quebec, H3T 1E2, Canada

Location

MeSH Terms

Conditions

FrailtyCognitive DysfunctionWounds and Injuries

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsCognition DisordersNeurocognitive DisordersMental Disorders

Study Officials

  • Olivier Beauchet, MD

    Jewish General Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, Professor of Geriatrics

Study Record Dates

First Submitted

June 14, 2019

First Posted

June 19, 2019

Study Start

May 31, 2020

Primary Completion

December 31, 2024

Study Completion

August 31, 2025

Last Updated

February 23, 2024

Record last verified: 2024-02

Locations

CA(1)